Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|October 24, 2009
In vivo interactions between BZP and TFMPP (party pill drugs)Ushtana Antia, Malcolm D Tingle, Bruce R Russell
The New Zealand Medical Journal|February 12, 2010
'Party pill' drugs--BZP and TFMPPUstana Antia, Malcolm D Tingle, Bruce R Russell
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2011
Glucuronidation of anticancer prodrug PR-104A: species differences, identification of human UDP-glucuronosyltransferases, and implications for therapyYongchuan Gu, Malcolm D Tingle, William R Wilson
The Journal of Pharmacy and Pharmacology|July 11, 2009
Metabolic interactions with piperazine-based 'party pill' drugsUshtana Antia, Malcolm D Tingle, Bruce R Russell
Cancer Chemotherapy and Pharmacology|September 21, 2005
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitroJocelyn L Carr, Malcolm D Tingle, Mark J McKeage
Cancer Chemotherapy and Pharmacology|July 12, 2002
Rapid biotransformation of satraplatin by human red blood cells in vitroJocelyn L Carr, Malcolm D Tingle, Mark J McKeage
Cancer Chemotherapy and Pharmacology|February 28, 2002
Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Shufeng Zhou, Philip Kestell, Malcolm D Tingle, et al.
Neuropharmacology|December 28, 2016
Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 miceAilsa L McGregor, Gary D'Souza, Donghyo Kim, et al.
Drugs & Aging|April 13, 2002
Thalidomide in cancer treatment: a potential role in the elderly?Shufeng Zhou, Philip Kestell, Malcolm D Tingle, et al.
Pageof 4